Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2024-09-30 00:00:00 ET · period of report 2024-09-27 · accession 0000950170-24-110484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-27 | VRDN | Mahoney Stephen F. | Pres, CEO, Dir | P - Purchase | $23.33 | +21.4K | 21.4K | New | +$499.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-27 | P | A | 21,400 | $23.33 | 21,400 | D | — | — |